Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

3.85
Delayed Data
As of Dec 09
 -0.01 / -0.26%
Today’s Change
2.63
Today|||52-Week Range
6.30
-28.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues670.0K640.0K610.0K610.0K
 
 
 
 
 
Depreciation And Amortization3.0K3.0K3.0K2.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses12.0M10.5M10.6M9.1M
 
 
 
 
 
Research And Development7.6M6.2M6.6M5.3M
 
 
 
 
 
Total Operating Expenses12.0M10.5M10.6M9.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.3M-9.9M-10.0M-8.5M
 
 
 
 
 
Interest Expense On Debt234.0K298.0K476.0K473.0K
 
 
 
 
 
Other Expenses-4.0K76.0K23.0K49.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.6M-10.1M-10.4M-9.0M
 
 
 
 
 
Net Income-11.6M-10.1M-10.4M-9.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.8M14.4M14.5M14.5M
 
 
 
 
 
Shares To Calculate EPS Diluted12.8M14.4M14.5M14.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.90-$0.72-$0.72-$0.62
 
 
 
 
 
EPS Diluted-$0.90-$0.72-$0.72-$0.62